89.83
Inhibrx Biosciences Inc (INBX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
-
|
- | - | - | 1.30 |
| Operating Expenses |
3.95%
32.15
|
30.93 | 30.92 | 33.81 | 28.69 |
| Operating Income/Loss |
3.95%
-32.15
|
-30.93 | -30.92 | -33.81 | -27.39 |
| Nonoperating Income/Loss |
78.92%
-4.498
|
-2.514 | -1.911 | -1.444 | -1.263 |
| Income/Loss From Continuing Operations Before Tax |
9.59%
-36.65
|
-33.44 | -32.83 | -35.26 | -28.65 |
| Income Tax Expense/Benefit |
0.003
|
- | - | - | 0.002 |
| Net Income/Loss |
9.60%
-36.65
|
-33.44 | -32.83 | -35.26 | -28.65 |
| Basic Average Shares |
0.54%
15.67
|
15.59 | - | 15.48 | 15.47 |
| Diluted Average Shares |
0.54%
15.67
|
15.59 | - | 15.48 | 15.47 |
| Basic Earnings Per Share |
8.84%
-2.34
|
-2.15 | - | -2.28 | -1.85 |
| Diluted Earnings Per Share |
8.84%
-2.34
|
-2.15 | - | -2.28 | -1.85 |
大文字化:
|
ボリューム (24 時間):